Dietary influences on intestinal immunity

Nature Reviews Immunology

Volumn 12, Issue 10, 2012, Pages 696-708

  Veldhoen, Marc ^a   Brucklacher Waldert, Verena ^a  

^a BABRAHAM INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; LIPID; LIVER X RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; RETINOL; VITAMIN; VITAMIN D;

CELL FUNCTION; DIETARY INTAKE; FAT INTAKE; FRUIT; HELPER CELL; HUMAN; INTESTINE MUCOSA; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY T LYMPHOCYTE; REVIEW; VEGETABLE;

ANIMALS; DIET; DIETARY FATS; FRUIT; HUMANS; IMMUNITY, MUCOSAL; INTESTINAL MUCOSA; INTESTINES; LYMPHOCYTES; PEYER'S PATCHES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; VEGETABLES;

EID: 84866673222     PISSN: 14741733     EISSN: 14741741     Source Type: Journal    
DOI: 10.1038/nri3299     Document Type: Review

References (122)

1. Eder, W., Ege, M. J. & von Mutius, E. The asthma epidemic. N. Engl. J. Med. 355, 2226-2235 (2006).
2. Maslowski, K. M. & Mackay, C. R. Diet, gut microbiota and immune responses. Nature Immunol. 12, 5-9 (2011).
3. Bach, J. F. The effect of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med. 347, 911-920 (2002).
4. Devereux, G. The increase in the prevalence of asthma and allergy: food for thought. Nature Rev. Immunol. 6, 869-874 (2006).
5. Hotamisligil, G. S. Inflammation and metabolic disorders. Nature 444, 860-867 (2006).
6. Fukuda, S. et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469, 543-547 (2011).
7. Macia, L. et al. Microbial influences on epithelial integrity and immune function as a basis for inflammatory diseases. Immunol. Rev. 245, 164-176 (2012).
8. Glass, C. K. & Ogawa, S. Combinatorial roles of nuclear receptors in inflammation and immunity. Nature Rev. Immunol. 6, 44-55 (2006).
9. Zygmunt, B. & Veldhoen, M. T helper cell differentiation: more than just cytokines. Adv. Immunol. 109, 159-196 (2011).
10. H2 inflammation. Nature 482, 395-399 (2012).
11. H17 and regulatory T cells. Nature 441, 235-238 (2006).
12. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198, 1875-1886 (2003).
13. Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M. & Stockinger, B. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24, 179-189 (2006).
14. + T cells. J. Exp. Med. 205, 1381-1393 (2008).
15. H17 cell differentiation by antagonizing RORγt function. Nature 453, 236-240 (2008).
16. + T helper cells. Cell 126, 1121-1133 (2006).
17. H17 cells occurs in the small intestine. Nature 475, 514-518 (2011).
18. H17 cells: shifting the focus to function. Nature Immunol. 11, 471-476 (2010).
19. Zhou, X. et al. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nature Immunol. 10, 1000-1007 (2009).
20. Ogawa, A., Andoh, A., Araki, Y., Bamba, T. & Fujiyama, Y. Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice. Clin. Immunol. 110, 55-62 (2004).
21. Monticelli, L A., Sonnenberg, G. F. & Artis, D. Innate lymphoid cells: critical regulators of allergic inflammation and tissue repair in the lung. Curr. Opin. Immunol. 24, 284-289 (2012).
22. Eberl, G. & Littman, D. R. The role of the nuclear hormone receptor RORyt in the development of lymph nodes and Peyer's patches. Immunol. Rev. 195, 81-90 (2003).
23. Zenewicz, L A. et al. Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 29, 947-957 (2008).
24. H17-cell-mediated autoimmunity to environmental toxins. Nature 453, 106-109 (2008).
25. Yang, X. O. et al. T helper 17 lineage differentiation is programmed by orphan nuclear receptors RORa and RORy. Immunity 28, 29-39 (2008).
26. Deeb, K. K., Trump, D. L & Johnson, C. S. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nature Rev. Cancer 7, 684-700 (2007).
27. Mora, J. R., Iwata, M. & von Andrian, U. H. Vitamin effects on the immune system: vitamins A and D take centre stage. Nature Rev. Immunol. 8, 685-698 (2008).
28. + regulatory T cells via a TGF-ß and retinoic acid-dependent mechanism. J. Exp. Med. 204, 1757-1764 (2007).
29. + regulatory T cells in the lamina propria. Immunity 34, 237-246 (2011).
30. Sun, C. M. et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 204, 1775-1785 (2007).
31. Iwata, M. et al. Retinoic acid imprints gut-homing specificity on T cells. Immunity 21, 527-538 (2004).
32. Elias, K. M. et al. Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway. Blood 111, 1013-1020 (2008).
33. Sigmundsdottir, H. et al. DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27. Nature Immunol. 8, 285-293 (2007).
34. H17 and regulatory T cell differentiation mediated by retinoic acid. Science 317, 256-260 (2007).
35. Takahashi, H. et al. TGF-ß and retinoic acid induce the microRNA miR-10a, which targets Bcl-6 and constrains the plasticity of helper T cells. Nature Immunol. 13, 587-595 (2012).
36. Benson, M. J., Pino-Lagos, K., Rosemblatt, M. & Noelle, R. J. All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J. Exp. Med. 204, 1765-1774 (2007).
37. hi cells. Immunity 29, 758-770 (2008).
38. Meseguer, S., Mudduluru, G., Escamilla, J. M., Allgayer, H. & Barettino, D. Micro-RNAs-10a and-10b contribute to retinoic acid-induced differentiation of neuroblastoma cells and target the alternative splicing regulatory factor SFRS1 (SF2/ASF). J. Biol. Chem. 286, 4150-4164 (2010).
39. DePaolo, R. W. et al. Co-adjuvant effects of retinoic acid and IL 15 induce inflammatory immunity to dietary antigens. Nature 471, 220-224 (2011).
40. + T cell effector responses via retinoic acid receptor a. Immunity 34, 435-447 (2011).
41. Nurieva, R. I. et al. Bcl6 mediates the development of T follicular helper cells. Science 325, 1001-1005 (2009).
42. Hirota, K. et al. Fate mapping of IL 17-producing T cells in inflammatory responses. Nature Immunol. 12, 255-263 (2011).
43. +regulatory T cells and inhibits development of Th17 cells by enhancing TGF-ß-driven Smad3 signaling and inhibiting IL-6 and IL23 receptor expression. J. Immunol. 181, 2277-2284 (2008).
44. Kang, S. W. et al. 1, 25-dihyroxyvitamin D3 promotes FOXP3 expression via binding to vitamin D response elements in its conserved noncoding sequence region. J. Immunol. 188, 5276-5282 (2012).
45. Mora, J. R. et al. Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells. Nature 424, 88-93 (2003).
46. + dendritic cells in the regulation of tissue-selective T cell homing. J. Exp. Med. 202, 1063-1073 (2005).
47. Mora, J. R. et al. Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells. Science 314, 1157-1160 (2006).
48. Wang, N. S. et al. Divergent transcriptional programming of class-specific B cell memory by T-bet and RORa. Nature Immunol. 13, 604-611 (2012).
49. + interleukin-4-mediated IgE production in vitro. Blood 92, 1713-1720 (1998).
50. Jeffery, L E. et al. 1, 25-dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J. Immunol. 183, 5458-5467 (2009).
51. von Essen, M. R. et al. Vitamin D controls T cell antigen receptor signaling and activation of human T cells. Nature Immunol. 11, 344-349 (2010).
52. DAmbrosio, D. et al. Inhibition of IL-12 production by 1, 25-dihydroxyvitamin D3. Involvement of NF-KB downregulation in transcriptional repression of the p40 gene. J. Clin. Invest. 101, 252-262 (1998).
53. Penna, G. & Adorini, L 1 a, 25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J. Immunol. 164, 2405-2411 (2000).
54. + cells in the draining lymph nodes. J. Immunol. 179, 6273-6283 (2007).
55. H17 cells to protect against experimental autoimmune encephalomyelitis. PLoS ONE 5, e12925 (2010).
56. Hirota, K. et al. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J. Exp. Med. 204, 2803-2812 (2007).
57. H-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nature Immunol. 10, 514-523 (2009).
58. Bruce, D. & Cantorna, M. T. Intrinsic requirement for the vitamin D receptor in the development of CD8aa-expressing T cells. J. Immunol. 186, 2819-2825 (2011).
59. + intestinal intraepithelial lymphocytes by TGF-ß. Nature Immunol. 12, 312-319 (2011).
60. H17 cell differentiation by the aryl hydrocarbon receptor. Nature 453, 65-71 (2008).
61. Kiss, E. A. et al. Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles. Science 334, 1561-1565 (2011).
62. Lee, J. S. et al. AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch. Nature Immunol. 13, 144-151 (2011).
63. Qiu, J. et al. The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells. Immunity 36, 92-104 (2011).
64. Li, Y. et al. Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation. Cell 147, 629-640 (2011).
65. Wincent, E. et al. The suggested physiologic aryl hydrocarbon receptor activator and cytochrome P4501 substrate 6-formylindolo[3, 2-b]carbazole is present in humans. J. Biol. Chem. 284, 2690-2696 (2009).
66. Bjeldanes, L. F., Kim, J. Y, Grose, K. R., Bartholomew, J. C. & Bradfield, C. A. Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo: comparisons with 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin. Proc. Natl Acad. Sci. USA 88, 9543-9547 (1991).
67. Knoop, K. A. & Newberry, R. D. Isolated lymphoid follicles are dynamic reservoirs for the induction of intestinal IgA. Front. Immunol. 3, 84 (2012).
68. Shi, H. et al. TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 116, 3015-3025 (2006).
69. Solinas, G., Naugler, W., Galimi, F, Lee, M. S. & Karin, M. Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin-receptor substrates. Proc. Natl Acad. Sci. USA 103, 16454-16459 (2006).
70. Wang, J., Wu, X., Simonavicius, N., Tian, H. & Ling, L. Medium-chain fatty acids as ligands for orphan G protein-coupled receptor GPR84. J. Biol. Chem. 281, 34457-34464 (2006).
71. Hirasawa, A. et al. Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nature Med. 11, 90-94 (2005).
72. Oh, D. Y. et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 142, 687-698 (2010).
73. Itoh, Y et al. Free fatty acids regulate insulin secretion from pancreatic ß cells through GPR40. Nature 422, 173-176 (2003).
74. Liou, A. P. et al. The G-protein-coupled receptor GPR40 directly mediates long-chain fatty acid-induced secretion of cholecystokinin. Gastroenterology 140, 903-912 (2011).
75. Martin, B., Hirota, K., Cua, D. J., Stockinger, B. & Veldhoen, M. Interleukin-17-producing yô T cells selectively expand in response to pathogen products and environmental signals. Immunity 31, 321-330 (2009).
76. Nyirenda, M. H. et al. TLR2 stimulation drives human naive and effector regulatory T cells into a Th17-like phenotype with reduced suppressive function. J. Immunol. 187, 2278-2290 (2011).
77. Oberg, H. H. et al. Differential but direct abolishment of human regulatory T cell suppressive capacity by various TLR2 ligands. J. Immunol. 184, 4733-4740 (2010).
78. + T lymphocytes promotes T helper 17 responses and regulates the pathogenesis of autoimmune disease. Immunity 32, 692-702 (2010).
79. Sutmuller, R. P. et al. Toll-like receptor 2 controls expansion and function of regulatory T cells. J. Clin. Invest. 116, 485-494 (2006).
80. Forman, B. M., Umesono, K., Chen, J. & Evans, R. M. Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell 81, 541-550 (1995).
81. Kliewer, S. A. et al. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor y and promotes adipocyte differentiation. Cell 83, 813-819 (1995).
82. Clark, R. B. et al. The nuclear receptor PPARy and immunoregulation: PPARy mediates inhibition of helper T cell responses. J. Immunol. 164, 1364-1371 (2000).
83. Dunn, S. E. et al. Peroxisome proliferator-activated receptor ô limits the expansion of pathogenic Th cells during central nervous system autoimmunity. J. Exp. Med. 207, 1599-1608 (2010).
84. Faveeuw, C. et al. Peroxisome proliferator-activated receptor y activators inhibit interleukin-12 production in murine dendritic cells. FEBS Lett. 486, 261-266 (2000).
85. Li, B., Reynolds, J. M., Stout, R. D., Bernlohr, D. A. & Suttles, J. Regulation of Th17 differentiation by epidermal fatty acid-binding protein. J. Immunol. 182, 7625-7633 (2009).
86. Wang, L. H. et al. Transcriptional inactivation of STAT3 by PPARy suppresses IL-6-responsive multiple myeloma cells. Immunity 20, 205-218 (2004).
87. Klotz, L. et al. The nuclear receptor PPARy selectively inhibits Th17 differentiation in a T cell-intrinsic fashion and suppresses CNS autoimmunity. J. Exp. Med. 206, 2079-2089 (2009).
88. Feuerer, M. et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nature Med. 15, 930-939 (2009).
89. Cipolletta, D. et al. PPAR-y is a major driver of the accumulation and phenotype of adipose tissue T cells. Nature 486, 549-553 (2012).
90. Janowski, B. A. et al. Structural requirements of ligands for the oxysterol liver X receptors LXRa and LXRß. Proc. Natl Acad. Sci. USA 96, 266-271 (1999).
91. Makishima, M. et al. Identification of a nuclear receptor for bile acids. Science 284, 1362-1365 (1999).
92. Vavassori, P., Mencarelli, A., Renga, B., Distrutti, E. & Fiorucci, S. The bile acid receptor FXR is a modulator of intestinal innate immunity. J. Immunol. 183, 6251-6261 (2009).
93. Joseph, S. B., Castrillo, A., Laffitte, B. A., Mangelsdorf, D. J. & Tontonoz, P. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nature Med. 9, 213-219 (2003).
94. A-Gonzalez, N. et al. Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. Immunity 31, 245-258 (2009).
95. Bensinger, S. J. et al. LXR signaling couples sterol metabolism to proliferation in the acquired immune response. Cell 134, 97-111 (2008).
96. Cui, G. et al. Liver X receptor (LXR) mediates negative regulation of mouse and human Th17 differentiation. J. Clin. Invest. 121, 658-670 (2011).
97. Kallen, J. A. et al. X-ray structure of the hRORa LBD at 1.63 A: structural and functional data that cholesterol or a cholesterol derivative is the natural ligand of RORa. Structure 10, 1697-1707 (2002).
98. Boismenu, R. & Havran, W L. Modulation of epithelial cell growth by intraepithelial yô T cells. Science 266, 1253-1255 (1994).
99. Ismail, A. S. et al. yô intraepithelial lymphocytes are essential mediators of host-microbial homeostasis at the intestinal mucosal surface. Proc. Natl Acad. Sci. USA 108, 8743-8748 (2011).
100. Amre, D. K. et al. Imbalances in dietary consumption of fatty acids, vegetables, and fruits are associated with risk for Crohn's disease in children. Am. J. Gastroenterol. 102, 2016-2025 (2007).
101. Hou, J. K., Abraham, B. & El-Serag, H. Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am. J. Gastroenterol. 106, 563-573 (2011).
102. Arnson, Y., Amital, H. & Shoenfeld, Y. Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann. Rheum. Dis. 66, 1137-1142 (2007).
103. Lochner, M. et al. Microbiota-induced tertiary lymphoid tissues aggravate inflammatory disease in the absence of RORyt and LTi cells. J. Exp. Med. 208, 125-134 (2011).
104. +CD4-CD8-entheseal resident T cells. Nature Med. 18, 1069-1076 (2012).
105. Lawrence, T., Willoughby, D. A. & Gilroy, D. W Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nature Rev. Immunol. 2, 787-795 (2002).
106. Kliewer, S. A. et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors a and y. Proc. Natl Acad. Sci. USA 94, 4318-4323 (1997).
107. Kumar, S. Molecular clocks: four decades of evolution. Nature Rev. Genet. 6, 654-662 (2005).
108. Cordain, L. et al. Origins and evolution of the Western diet: health implications for the 21st century. Am. J. Clin. Nutr. 81, 341-354 (2005).
109. Willett, W. C. Balancing life-style and genomics research for disease prevention. Science 296, 695-698 (2002).
110. Cerf-Bensussan, N. & Gaboriau-Routhiau, V The immune system and the gut microbiota: friends or foes? Nature Rev. Immunol. 10, 735-744 (2010).
111. Hooper, L. V & Macpherson, A. J. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nature Rev. Immunol. 10, 159-169 (2010).
112. + dendritic cells in the small intestine. Nature 483, 345-349 (2012).
113. Cherrier, M. & Eberl, G. The development of LTi cells. Curr. Opin. Immunol. 24, 178-183 (2012).
114. Atarashi, K. et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331, 337-341 (2011).
115. Gaboriau-Routhiau, V et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 31, 677-689 (2009).
116. Veldhoen, M., Hocking, R. J., Flavell, R. A. & Stockinger, B. Signals mediated by transforming growth factor-ß initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease. Nature Immunol. 7, 1151-1156 (2006).
117. Yu, D. et al. The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment. Immunity 31, 457-468 (2009).
118. + innate lymphocytes. Immunity 33, 736-751 (2010).
119. + innate lymphoid cells. Science 330, 665-669 (2010).
120. Wong, S. H. et al. Transcription factor RORa is critical for nuocyte development. Nature Immunol. 13, 229-236 (2012).
121. Eberl, G. et al. An essential function for the nuclear receptor RORyt in the generation of fetal lymphoid tissue inducer cells. Nature Immunol. 5, 64-73 (2004).
122. Sonnenberg, G. F, Fouser, L. A. & Artis, D. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nature Immunol. 12, 383-390 (2011).